Cargando…
Exosomes/miRNAs as mediating cell-based therapy of stroke
Cell-based therapy, e.g., multipotent mesenchymal stromal cell (MSC) treatment, shows promise for the treatment of various diseases. The strong paracrine capacity of these cells and not their differentiation capacity, is the principal mechanism of therapeutic action. MSCs robustly release exosomes,...
Autores principales: | Xin, Hongqi, Li, Yi, Chopp, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4226157/ https://www.ncbi.nlm.nih.gov/pubmed/25426026 http://dx.doi.org/10.3389/fncel.2014.00377 |
Ejemplares similares
-
The Tumor Cytosol miRNAs, Fluid miRNAs, and Exosome miRNAs in Lung Cancer
por: Qin, Xin, et al.
Publicado: (2015) -
Cell‐Based and Exosome Therapy in Diabetic Stroke
por: Venkat, Poornima, et al.
Publicado: (2018) -
Advances in the diagnosis of exosomal miRNAs in ischemic stroke
por: Yu, Pei, et al.
Publicado: (2019) -
Increased Circulating Exosomal miRNA-223 Is Associated with Acute Ischemic Stroke
por: Chen, Yajing, et al.
Publicado: (2017) -
Exosomal Proteins and miRNAs as Mediators of Amyotrophic Lateral Sclerosis
por: Chen, Qiao Yi, et al.
Publicado: (2021)